Aspirin for Primary Prevention: What’s a Clinician to Do?
Open Access
- 2 December 2014
- journal article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 30 (2) , 147-149
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Do Clinicians Recommend Aspirin to Patients for Primary Prevention of Cardiovascular Disease?Journal of General Internal Medicine, 2014
- Patient-Accessible Tool for Shared Decision Making in Cardiovascular Primary PreventionCirculation, 2014
- The New Cholesterol and Blood Pressure GuidelinesJAMA, 2014
- Aspirin in Primary Prevention of Cardiovascular Disease and Cancer: A Systematic Review of the Balance of Evidence from Reviews of Randomized TrialsPLOS ONE, 2013
- Effect of Aspirin on Vascular and Nonvascular OutcomesArchives of internal medicine (1960), 2012
- Primary and Secondary Prevention of Cardiovascular DiseaseChest, 2012
- Aspirin for Primary Prevention of Cardiovascular Events in People With DiabetesCirculation, 2010
- Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsThe Lancet, 2009
- Aspirin for the Prevention of Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2009